Search Results

Study Shows Acceptable Long-Term Patency of SFA Stents

November 16, 2012—At the VEITH Symposium in New York City, Giovanni Torsello, MD, presented data showing that more than half of patients treated for claudication or critical limb ischemia (CLI) with stenting of the superficial femoral artery (SFA) retained primary patency at 5 years.

European Results Reported for Endurant Stent Graft at 1 Year

December 23, 2009—In the Journal of Vascular and Interventional Radiology, Giovanni Torsello, MD, et al published findings from a study conducted to assess preliminary results of the Endurant stent graft (Medtronic, Inc., Minneapolis, MN), which was developed to treat patients with abdominal aortic aneurysms (AAAs) and challenging aortoiliac anatomy (2010;21:73–80).

One-Year European Experience Reported for EVAR With Medtronic's Endurant Stent Graft

December 23, 2009—In the Journal of Vascular and Interventional Radiology, Giovanni Torsello, MD, et al published findings from a study conducted to assess preliminary results of the Endurant stent graft (Medtronic, Inc., Minneapolis, MN), which was developed to treat patients with abdominal aortic aneurysms (AAAs) and challenging aortoiliac anatomy (2010;21:73–80).

Four-Year INNOVATION Results Support Cordis InCraft AAA Stent Graft System

November 19, 2015—Cordis Corporation, a Cardinal Health company, announced that 4-year data from its INNOVATION of the InCraft abdominal aortic aneurysms (AAA) stent graft system trial were presented by study investigator Prof.

Bolton Medical Reports Initial Case From Limited Launch of Treo System in Europe

October 16, 2015—Bolton Medical, a subsidiary of the WerfenLife Company, announced the first commercial implantation of the Treo abdominal stent graft system was performed by Theodosios Bisdas, MD, and Professor Giovanni Torsello, MD, Director of the Center for Vascular and Endovascular Surgery at St.

Gore's TAG Conformable Thoracic Stent Graft With Active Control System Approved in Europe

July 13, 2017—Gore & Associates announced the first patient implant of its TAG conformable thoracic stent graft with Active Control System, which received European CE Mark approval in June for thoracic endovascular aortic repair (TEVAR).

Long-Term Data Presented for Medtronic's Endurant AAA Stent Graft

April 18, 2014—Medtronic, Inc. (Santa Rosa, CA) announced that new clinical data supporting the company’s Endurant abdominal aortic aneurysm (AAA) stent graft system were presented at the 35th Charing Cross International Symposium, which was held April 5–8 in London, United Kingdom.